Recombinant Human IL-8/CXCL8 (Mucin Stalk Chimera) Protein
R&D Systems, part of Bio-Techne | Catalog # 968-IL
Key Product Details
Product Specifications
Source
Human IL-8 (Ala23-Ser99) (Asn98Gly) & (Ser28-Ser99) (Asn98Gly) Accession # P10145 |
Human Fractalkine Mucin-like Stalk (Phe103-Gln341) Accession # P78423 |
KQN | 6-His tag |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 5-25 ng/mL.
Formulation, Preparation and Storage
Carrier Free
What does CF mean?CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
What formulation is right for me?In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
Carrier: 968-IL
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 25 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Carrier Free: 968-IL/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: IL-8/CXCL8
References
- Lazennec, G. and A. Richmond (2010) Trends Mol. Med. 16:133.
- Nesmelova, I.V. et al. (2005) J. Biol. Chem. 280:4948.
- Pichert, A. et al. (2012) Biomatter 2:142.
- Schmid, J. and C. Weissmann (1987) J. Immunol. 139:250.
- Mortier, A. et al. (2008) Pharmacol. Ther. 120:197.
- Proost, P. et al. (2008) J. Exp. Med. 205:2085.
- Neote, K. et al. (1994) Blood 84:44.
- Munoz, L.M. et al. (2009) J. Immunol. 183:7337.
- Gerszten, R.E. et al. (1999) Nature 398:718.
- Jones, S.A. et al. (1996) Proc. Natl. Acad. Sci. USA 93:6682.
- Bergin, D.A. et al. (2010) J. Clin. Invest. 120:4236.
- Apostolakis, S. et al. (2009) Cardiovasc. Res. 84:353.
- Martin, D. et al. (2009) J. Biol. Chem. 284:6038.
- Li, A. et al. (2005) Angiogenesis 8:63.
- Waugh, D.J. and C. Wilson (2008) Clin. Cancer Res. 14:6735.
- Fernando, R.I. et al. (2011) Cancer Res. 71:5296.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional IL-8/CXCL8 Products
Product Documents for Recombinant Human IL-8/CXCL8 (Mucin Stalk Chimera) Protein
Product Specific Notices for Recombinant Human IL-8/CXCL8 (Mucin Stalk Chimera) Protein
For research use only